QI
WVE icon

QS Investors’s Wave Life Sciences WVE Stock Holding History

QS Investors’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$441K Buy
+66,200
New +$433K 0.01% 792

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

QS Investors's WVE Position: Q2 2021 in Review

QS Investors opened a new position in Wave Life Sciences (WVE) in Q2 2021: 66,200 shares worth $441K. The stake represents 0.01% of the portfolio and ranks #792 among its holdings.

87 funds tracked by Wall St. Rank hold WVE as of Q2 2021.

  • QS Investors held 66,200 shares of Wave Life Sciences worth $441K as of Q2 2021.
  • Wave Life Sciences was a new QS Investors position in Q2 2021.
  • Wave Life Sciences made up 0.01% of QS Investors's portfolio in Q2 2021, its #792 holding.
  • 87 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.